Ticker Symbol: BLPH
Bellerophon Therapeutics Inc
$3.59 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001600132
Company Profile
bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 184 Liberty Corner Rd Ste 302
Website: http://www.bellerophon.com/
CEO: Fabian Tenenbaum
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.10
Change:
-$0.28
(
-73.39%)
Days Range: $0.05 - $0.10
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change -73.39%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 12232648
Valuation
Market Cap: 125.4M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A